Additional studies have reported that synthesized phosphorylated A2AR agonists (prodrugs) that need the ecto-5′-nucleotidase (CD73)-mediated de-phosphorylation in order to be activated, were tested in a murine model of collagen-induced arthritis. This evidence concerns the gene ADORA2A and arthritic joint disease.